SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-12-006102
Filing Date
2012-02-06
Accepted
2012-02-06 16:57:27
Documents
5
Period of Report
2012-01-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v301436_8k.htm 8-K 22956
2 EXHIBIT 99.1 v301436_ex99-1.htm EX-99.1 14382
3 EXHIBIT 99.2 v301436_ex99-2.htm EX-99.2 15174
4 GRAPHIC image_001.jpg GRAPHIC 2750
5 GRAPHIC image_003.jpg GRAPHIC 2750
  Complete submission text file 0001144204-12-006102.txt   61893
Mailing Address 9640 MEDICAL CNTR SR STE 200 ROCKVILLE MD 20850
Business Address 9640 MEDICAL CNTR DR STE 200 ROCKVILLE MD 20850 3012179858
ENTREMED INC (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20713 | Film No.: 12574297
SIC: 2836 Biological Products, (No Diagnostic Substances)